1 |
Carter, W. J., Myles, T., Gibbs, C. S., Leung, L. L., and Huntington, J. A., Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery. J. Biol. Chem., 279, 26387-26394 (2004)
DOI
ScienceOn
|
2 |
Cho, J., Seo, H., Yun, C., Koo, B., Yoshida, S., Koga, T., Dan, T., and Kim, H., In vitro and in vivo stuies of AT-1362, a newly synthesized and orally active inhibitor of thrombin. Thromb. Res., 100, 97-107 (2000)
DOI
ScienceOn
|
3 |
Cho, H. R. and Choi, H. S. Effects of anticoagulant from Spirodela polyrhiza in rats. Biosci. Biotechnol. Biochem., 67, 881-883 (2003)
DOI
ScienceOn
|
4 |
Herbert, J. M., Herault, J. P., Bernat, A., van Amsterdam, R. G. M., lormeau, J. C., Petitou, M., van Boeckel, C., Hoffmann, P., and Meuleman, D. G., Biochemical and pharmacological properties of Sanorg 34006, a potent and long-acting synthetic pentasaccharide. Blood, 91, 4197-4205 (1998)
|
5 |
Jakubowski, J. A. and Maraganore, J. M., Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin. Blood, 75, 399-406 (1990)
|
6 |
Kang, K. T., Jung, B. I., Bae, O. N., Lee, M. Y., Chung, S. M., Lee, J. Y., Lee, S. K., Kim, I. C., and Chung, J. H., Antithrombotic activity of LB30057, a newly synthesized direct thrombin inhibitor. Thromb. Haemost., 89,104-111 (2003)
|
7 |
Lettino, M. and Toschi, V., Direct antithrombins: new perspectives in cardiovascular medicine. Curr. Med. Chem. Cardiovasc. Hematol. Agents, 2, 267-275 (2004)
DOI
ScienceOn
|
8 |
Liu, F., Craft, R. M., Morris, S. A., and Carroll, R. C., Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker. Expert. Opin. Investig. Drugs, 9, 2673-2687 (2000)
DOI
ScienceOn
|
9 |
Noeske-Jungblut, C., Haendler, B., Donner, P., Alagon, A., Possani, L., and Schleu ning, W-D., Triabin, a highly potent exosite inhibitor of thrombin. J. Biol. Chem., 270, 28629-28634 (1995)
DOI
|
10 |
Olson, S. T., Bjo, I., Sheffer, R., Craig, P. A., Shore, J. D., and Choay, J., Role of the antithrombin-binding pentasaccharides in heparin acceleration of antithrombin-proteinase reactions. J. Biol. Chem., 267, 12528-12538 (1992)
|
11 |
Wall, D., Douglas, S., Ferro, V., Cowden, W., and Parish, C., Characterisation of the anticoagulant properties of a range of structurally diverse sulfated oligosaccharides. Thromb. Res., 103, 325-335 (2001)
DOI
ScienceOn
|
12 |
Markwardt, F., Hirudin as alternative anticoagulant-a historical review. Semin. Thromb. Hemost., 28, 405-414 (2002)
DOI
PUBMED
ScienceOn
|
13 |
Renda, G., Rocca, B., Crocchiolo, R., Cristofaro, R.D., and Landolfi, R., Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban. Thromb. Haemost., 89, 348-354 (2003)
|
14 |
Tsiang, M., Lentz, S. R., Dittman, W. A., Wen, D., Scarpati, E. M., and Sadler, J. E., Equilibrium binding of thrombin to recombinant human thrombomodulin: effect of hirudin, fibrinogen, factor Va, and peptide analogues. Biochemistry, 29, 10602-10612 (1990)
DOI
ScienceOn
|
15 |
Choi, H. S. and Sa, Y. S., Fibrinolytic and antithrombotic protease from Spirodela polyrhiza. Biosci. Biotechnol. Biochem., 65, 781-786 (2001)
DOI
ScienceOn
|
16 |
Moon, K. S., In Usage of Herbal Medicine (ed. Choi, O. J.), pp 466-468, Ilwolseogak (1991)
|
17 |
McClanahan, T. B., Hicks, G. W., Morrison, A. L., Peng, Y. W., Janiczek-Dolphin, N., Mertz, T. E., Sullivan, M. E., Morser, J., Juneau, P. L., and Leadley, R., The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis. Eur. J. Pharmacol., 432,187-194 (2001)
DOI
PUBMED
ScienceOn
|
18 |
McGowan, E. B. and Detwiler, T. C., Modified platelet responses to thrombin. Evidence for two types of receptors or coupling mechanisms. J. Biol. Chem., 261, 739-746 (1986)
|
19 |
Wong, P. C., Crain, E. J., Watson, C. A., Zaspel, A. M., Wright, M. R., Lam, P. Y., Pinto, D. J., Wexler, R. R., and Knabb, R. M., Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits. J. Pharmacol. Exp. Ther., 303, 993-1000 (2002)
DOI
ScienceOn
|
20 |
Stubbs, M. T., Oschkinat, H., Mayr, I., Huber, R., Angliker, H., Stone, S. R., and Bode, W., The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur. J. Biochem., 206, 187-195 (1992)
DOI
ScienceOn
|
21 |
Rezaie, A. R., Cooper, S. T., Church, F. C., and Esmon, C. T., Protein C inhibitor is a potent inhibitor of the thrombinthrombomodulin complex. J. Biol. Chem., 270, 25336-25339 (1995)
DOI
ScienceOn
|
22 |
Friedrich, T., Kroger, B., Bialojan, S., Lemaire, H. G., Hoffken, H. W., Reuschenbach, P., Otte, M., and Dodt, J., A kazal-type inhibitor with thrombin specificity from Rhodnius prolixus. J. Biol. Chem., 268, 16216-16222 (1993)
|
23 |
Yuk, D. Y., Ryu, C. K., Hong, J. T., Chung, K. H., Kang, W. S., Kim, Y., Yoo, H. S., Lee, M. K., Lee, C. K., and Yun, Y. P., Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative. Biochem. Pharmacol., 60, 1001-1008 (2000)
DOI
ScienceOn
|
24 |
Hofmann, W. and Bon, C., blood coagulation induced by the venom of Bothrops atrox. 1. Identification, purification, and properties of a prothrombin activator. Biochemistry, 26, 772-776 (1987)
DOI
ScienceOn
|
25 |
Strube, K.-H., Kroger, B., Bialojan, S., Otte, M., and Dodt, J., Isolation, sequence analysis, and cloning of haemadin. J. Biol. Chem., 268, 8590-8595 (1993)
|
26 |
Muramatsu, R., Sasaki, M., Watanabe, N., Goto, Y., Okayama, T., Nukui, E., Morikawa, T., and Hayashi, H., Antithrombotic effects of NE-6505, a novel anion-binding exosite inhibitor. Thromb. Res., 86, 453-460 (1997)
DOI
ScienceOn
|
27 |
Naski, M. C., Fenton II, J. W., Maraganore, J. M., Olson, S. T., and Shafer, J. A., The COOH-terminal domain of hirudin. J. Biol. Chem., 265, 13484-13489 (1990)
|
28 |
Holsat, J., Lindblad, B., and Bergqvist, D., Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis-a comparison with low molecular weight heparin. Thromb. Haemost., 71, 214-219 (1994)
|
29 |
Okonogi, T., Hattori, Z., Ogiso, A., and Mitsui, S., Detoxification by persimmon tannin of snake venoms and bacterial toxins. Toxicon, 17, 524-527 (1979)
DOI
ScienceOn
|
30 |
Richardson, J. L., Kroger, B., Hoeffken, W., Sadler, J. E., Pereira, P., Huber, R., Bode, W., and Fuentes-Prior, P., Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. EMBO J., 19, 5650-5660 (2000)
DOI
PUBMED
ScienceOn
|
31 |
Sa, Y. S., Kim, K. A., and Choi, H. S., Purification and characterization of anti-coagulant activity from persimmon stem. J. Kor. Soc. Food Sci. Nutr., 32, 1323-1327 (2003)
과학기술학회마을
DOI
|